GET THE APP

Hypertensive Nephropathy: Huangqi Injection Treatment | 95786

卫生经济学与结果研究:开放获取

ISSN - 2471-268X

抽象的

Hypertensive Nephropathy: Huangqi Injection Treatment

Wiatt Iluka

The extract of Astragalus membranaceus (Fisch.) Bunge is known as uangqi injection (HQI), and it is frequently used in China to treat a wide range of illnesses. It is expected to have a significant role in hypertensive nephropathy adjuvant therapy.

HQI and antihypertensive medications should be evaluated for their effectiveness in treating hypertensive nephropathy. When combined with antihypertensive medications, HQI is more effective than antihypertensive medications alone at improving associated indexes in patients with hypertensive nephropathy, and a moderate dose of HQI may be more beneficial. The methodology's poor quality and the study's small sample size mean that further rigorous randomised controlled trials are required to corroborate the findings.

免责声明: 该摘要是使用人工智能工具翻译的,尚未经过审查或验证。